These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 26392377)
1. The role of the transcription factor Ets1 in carcinoma. Dittmer J Semin Cancer Biol; 2015 Dec; 35():20-38. PubMed ID: 26392377 [TBL] [Abstract][Full Text] [Related]
2. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells. Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276 [TBL] [Abstract][Full Text] [Related]
3. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2, dependent on ERK1/2 activity, in breast cancer cells. Sinh ND; Endo K; Miyazawa K; Saitoh M Cancer Sci; 2017 May; 108(5):952-960. PubMed ID: 28247944 [TBL] [Abstract][Full Text] [Related]
4. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340 [TBL] [Abstract][Full Text] [Related]
5. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets. Schmidt M; Schmidt AM; Dietl J; Kammerer U Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671 [TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma. Gluck C; Glathar A; Tsompana M; Nowak N; Garrett-Sinha LA; Buck MJ; Sinha S PLoS Genet; 2019 Jul; 15(7):e1008250. PubMed ID: 31306413 [TBL] [Abstract][Full Text] [Related]
7. [How tumors abuse their host: the transcription factor c-ets1 and the regulation of tumor angiogenesis or invasion]. Vandenbunder B; Wernert N; Stéhelin D Contracept Fertil Sex; 1994 Oct; 22(10):656-60. PubMed ID: 7528601 [TBL] [Abstract][Full Text] [Related]
8. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming. Bhattacharya R; Ray Chaudhuri S; Roy SS J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943 [TBL] [Abstract][Full Text] [Related]
9. Drug resistant breast cancer cells overexpress ETS1 gene. Kars MD; Işeri OD; Gündüz U Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592 [TBL] [Abstract][Full Text] [Related]
10. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes. Bendinelli P; Maroni P; Matteucci E; Desiderio MA Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415 [TBL] [Abstract][Full Text] [Related]
11. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Wang R; Ma Y; Yu D; Zhao J; Ma P Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481 [TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 beta (GSK3β)-mediated phosphorylation of ETS1 promotes progression of ovarian carcinoma. Tsai CL; Jung SM; Chi LM; Tsai CN; Lin CY; Chao A; Lee YS Aging (Albany NY); 2021 May; 13(10):13739-13763. PubMed ID: 34023818 [TBL] [Abstract][Full Text] [Related]
13. The biology of the Ets1 proto-oncogene. Dittmer J Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829 [TBL] [Abstract][Full Text] [Related]
14. Uncovering a Key Role of ETS1 on Vascular Abnormality in Glioblastoma. Tang J; Li Y; Liu B; Liang W; Hu S; Shi M; Zeng J; Li M; Huang M Pathol Oncol Res; 2021; 27():1609997. PubMed ID: 34867089 [TBL] [Abstract][Full Text] [Related]
15. ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression. Kato T; Fujita Y; Nakane K; Kojima T; Nozawa Y; Deguchi T; Ito M Biochem Biophys Res Commun; 2012 Jan; 417(3):966-71. PubMed ID: 22206665 [TBL] [Abstract][Full Text] [Related]
16. Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Nelson ML; Kang HS; Lee GM; Blaszczak AG; Lau DK; McIntosh LP; Graves BJ Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10026-31. PubMed ID: 20534573 [TBL] [Abstract][Full Text] [Related]
17. Importance of ets1 proto-oncogene for breast cancer progression. Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378 [TBL] [Abstract][Full Text] [Related]
18. A Role for Autoinhibition in Preventing Dimerization of the Transcription Factor ETS1. Samorodnitsky D; Szyjka C; Koudelka GB J Biol Chem; 2015 Sep; 290(36):22101-10. PubMed ID: 26195629 [TBL] [Abstract][Full Text] [Related]
19. ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy. Lu L; Zhong Z; Gu J; Nan K; Zhu M; Miao C Mol Med; 2021 Jul; 27(1):74. PubMed ID: 34238215 [TBL] [Abstract][Full Text] [Related]
20. Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2. Plotnik JP; Hollenhorst PC Nucleic Acids Res; 2017 May; 45(8):4452-4462. PubMed ID: 28119415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]